Epigenetic maps already completed of human embryonic stem (HES) cells and induced pluripotent stem (iPS) cells have reportedly shown significant differences, with potential implications for the development of stem cell therapeutics - although other work reported earlier this year that epigenetic and transcriptional profiles had revealed high levels of equivalence between HES and iPS cells (see previous news). 

comments powered by Disqus